Literature DB >> 17147465

Risk factors for rhabdomyolysis with simvastatin and atorvastatin.

Beatrice Golomb, Marcella Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17147465     DOI： 10.2165/00002018-200629120-00009

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  2 in total

1.  Risk factors for rhabdomyolysis with simvastatin and atorvastatin.

Authors:  Kathlyn J Ronaldson; Justine M O'Shea; Ian W Boyd
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1997-07-01       Impact factor: 2.778
  2 in total
  3 in total

Review 1.  Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.

Authors:  Zhining Wen; Yu Liang; Yingyi Hao; Brian Delavan; Ruili Huang; Mike Mikailov; Weida Tong; Menglong Li; Zhichao Liu
Journal:  Drug Discov Today       Date:  2018-06-11       Impact factor: 7.851

2.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.